Evidence map›Paper›PMID 41685350›Full record

ArticleNAR genomics and bioinformatics2026

An ELIXIR scoping review on domain-specific evaluation metrics for synthetic data in life sciences.

Styliani-Christina Fragkouli, Somya Iqbal, Lisa Crossman, Barbara Gravel, Nagat Masued, Mark Onders, Devesh Haseja, Alex Stikkelman, Alfonso Valencia, Tom Lenaerts and 4 more

Abstract readScoping Review
In one paragraph

Article in NAR genomics and bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Styliani-Christina FragkouliDepartment of Biology, National and Kapodistrian University of Athens, Athens 15772, Greece.ORCID https://orcid.org/0000-0003-4067-7123
Somya IqbalUniversity of Edinburgh, Usher Institute, Nine BioQuarter, Edinburgh EH16 4UX, United Kingdom.
Lisa CrossmanSequenceAnalysis.co.uk, Norwich Research Park, Norwich NR4 7UG, United Kingdom.
Barbara GravelInteruniversity Institute of Bioinformatics in Brussels, Université Libre de Bruxelles-Vrije Universiteit Brussel, Brussels 1050, Belgium.ORCID https://orcid.org/0000-0002-5422-2376
Nagat MasuedBarcelona Supercomputing Center (BSC), Plaça Eusebi Güell, 1-3, Barcelona 08034, Spain.
Mark OndersDepartment of Applied and Computational Mathematics and Statistics, University of Notre Dame, Notre Dame, IN 46556, United States.
Devesh HasejaSchool of Mathematical and Statistical Sciences, College of Science and Engineering, University of Galway, Galway, H91 TK33, Ireland.
Alex StikkelmanDepartment of Human Genetics, Leiden University Medical Center, Leiden 2333, The Netherlands.
Alfonso ValenciaBarcelona Supercomputing Center (BSC), Plaça Eusebi Güell, 1-3, Barcelona 08034, Spain.
Tom LenaertsInteruniversity Institute of Bioinformatics in Brussels, Université Libre de Bruxelles-Vrije Universiteit Brussel, Brussels 1050, Belgium.
Fotis PsomopoulosInstitute of Applied Biosciences, Centre for Research & Technology Hellas, Thessaloniki 57001, Greece.ORCID https://orcid.org/0000-0002-0222-4273
Pilib Ó BroinSchool of Mathematical and Statistical Sciences, College of Science and Engineering, University of Galway, Galway, H91 TK33, Ireland.
Núria Queralt-RosinachDepartment of Human Genetics, Leiden University Medical Center, Leiden 2333, The Netherlands.
Davide CirilloBarcelona Supercomputing Center (BSC), Plaça Eusebi Güell, 1-3, Barcelona 08034, Spain.ORCID https://orcid.org/0000-0003-4982-4716

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthetic data (SD) has become an increasingly important asset in the life sciences, helping address data scarcity, privacy concerns, and barriers to data access. Creating artificial datasets that mirror the characteristics of real data allows researchers to develop and validate computational methods in controlled environments. Despite its promise, the adoption of SD in life sciences hinges on rigorous evaluation metrics designed to assess their fidelity and reliability. To explore the current landscape of SD evaluation metrics in distinct life sciences domains, the ELIXIR Machine Learning Focus Group performed a systematic review of the scientific literature following the PRISMA guidelines. Six critical domains were examined to identify current practices for assessing SD. Findings reveal that, while generation methods are rapidly evolving, systematic evaluation is often overlooked, limiting researchers' ability to compare, validate, and trust synthetic datasets across different domains. This systematic review underscores the urgent need for robust, standardized evaluation approaches that not only bolster confidence in SD but also guide its effective and responsible implementation. By laying the groundwork for establishing domain-specific yet interoperable standards, this scoping review paves the way for future initiatives aimed at enhancing the role of SD in scientific discovery, clinical practice and beyond.

Indexed as

Biological Science DisciplinesSynthetic BiologyHumansMachine LearningReproducibility of Results

Identifiers

PMID41685350
PMCPMC12891913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.